Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations for Ovarian Cancer
Recruiting1 awardPhase 1
Bethesda, Maryland
"This trial aims to test a new cancer treatment that uses a person's own modified white blood cells along with a vaccine to target specific proteins found in cancer cells. Adults with certain types of cancer that have
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.